1. Home
  2. XBIO vs FRSX Comparison

XBIO vs FRSX Comparison

Compare XBIO & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

N/A

Current Price

$2.41

Market Cap

5.9M

Sector

Health Care

ML Signal

N/A

Logo Foresight Autonomous Holdings Ltd.

FRSX

Foresight Autonomous Holdings Ltd.

HOLD

Current Price

$1.90

Market Cap

6.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIO
FRSX
Founded
N/A
N/A
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
6.3M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
XBIO
FRSX
Price
$2.41
$1.90
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
47.5K
562.7K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,858,935.00
$452,000.00
Revenue This Year
$1.99
N/A
Revenue Next Year
$20.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.30
N/A
52 Week Low
$2.20
$1.75
52 Week High
$13.93
$18.41

Technical Indicators

Market Signals
Indicator
XBIO
FRSX
Relative Strength Index (RSI) 40.78 38.12
Support Level $2.31 $1.76
Resistance Level $2.64 $1.88
Average True Range (ATR) 0.18 0.08
MACD 0.05 -0.02
Stochastic Oscillator 31.65 26.09

Price Performance

Historical Comparison
XBIO
FRSX

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

Share on Social Networks: